salt-inducible-kinase modulators (National Institute of Biomedical Innovation)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesalt-inducible-kinase modulators (National Institute of Biomedical Innovation)
Drug Alias NameSIK modulators (National Institute of Biomedical Innovation)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSalt-inducible kinase 3 modulators
TargetsSalt-inducible kinase 3
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Biomedical Innovation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute Of Biomedical Innovation
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A